Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H12N2O8 |
| Molecular Weight | 288.2109 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C(=O)NC(=O)C=C2C(O)=O
InChI
InChIKey=FKCRAVPPBFWEJD-XVFCMESISA-N
InChI=1S/C10H12N2O8/c13-2-4-6(15)7(16)8(20-4)12-3(9(17)18)1-5(14)11-10(12)19/h1,4,6-8,13,15-16H,2H2,(H,17,18)(H,11,14,19)/t4-,6-,7-,8-/m1/s1
| Molecular Formula | C10H12N2O8 |
| Molecular Weight | 288.2109 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Conditions affecting the colorimetry of orotic acid and orotidine in urine. | 1980 Mar |
|
| Optimization of allopurinol challenge: sample purification, protein intake control, and the use of orotidine response as a discriminative variable improve performance of the test for diagnosing ornithine carbamoyltransferase deficiency. | 1999 Jul |
|
| Successful living-donor liver transplantation from an asymptomatic carrier mother in ornithine transcarbamylase deficiency. | 2001 Mar |
|
| Analysis of pyrimidine synthesis "de novo" intermediates in urine and dried urine filter- paper strips with HPLC-electrospray tandem mass spectrometry. | 2004 Nov |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:09:43 GMT 2023
by
admin
on
Fri Dec 15 18:09:43 GMT 2023
|
| Record UNII |
B350MC02GZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
12240-8
Created by
admin on Fri Dec 15 18:09:43 GMT 2023 , Edited by admin on Fri Dec 15 18:09:43 GMT 2023
|
||
|
LOINC |
75125-5
Created by
admin on Fri Dec 15 18:09:43 GMT 2023 , Edited by admin on Fri Dec 15 18:09:43 GMT 2023
|
||
|
LOINC |
17870-7
Created by
admin on Fri Dec 15 18:09:43 GMT 2023 , Edited by admin on Fri Dec 15 18:09:43 GMT 2023
|
||
|
LOINC |
75148-7
Created by
admin on Fri Dec 15 18:09:43 GMT 2023 , Edited by admin on Fri Dec 15 18:09:43 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Orotidine
Created by
admin on Fri Dec 15 18:09:43 GMT 2023 , Edited by admin on Fri Dec 15 18:09:43 GMT 2023
|
PRIMARY | |||
|
m8243
Created by
admin on Fri Dec 15 18:09:43 GMT 2023 , Edited by admin on Fri Dec 15 18:09:43 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID90953435
Created by
admin on Fri Dec 15 18:09:43 GMT 2023 , Edited by admin on Fri Dec 15 18:09:43 GMT 2023
|
PRIMARY | |||
|
C008714
Created by
admin on Fri Dec 15 18:09:43 GMT 2023 , Edited by admin on Fri Dec 15 18:09:43 GMT 2023
|
PRIMARY | |||
|
25722
Created by
admin on Fri Dec 15 18:09:43 GMT 2023 , Edited by admin on Fri Dec 15 18:09:43 GMT 2023
|
PRIMARY | |||
|
314-50-1
Created by
admin on Fri Dec 15 18:09:43 GMT 2023 , Edited by admin on Fri Dec 15 18:09:43 GMT 2023
|
PRIMARY | |||
|
B350MC02GZ
Created by
admin on Fri Dec 15 18:09:43 GMT 2023 , Edited by admin on Fri Dec 15 18:09:43 GMT 2023
|
PRIMARY | |||
|
92751
Created by
admin on Fri Dec 15 18:09:43 GMT 2023 , Edited by admin on Fri Dec 15 18:09:43 GMT 2023
|
PRIMARY |